A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
    

concept

Triazolam

Catalogue

The therapeutic nightmare : the battle over the world's most controversial sleeping pill / John Abraham & Julie Sheppard.